日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease

依泽替米贝 10/瑞舒伐他汀 40 联合疗法在埃及高危动脉粥样硬化性心血管疾病患者中的疗效和安全性

Sobhy, Mohamed; Mahfouz Badran, Hala; Hassanein, Mahmoud; Rafla, Samir; Zawawy, Tarek; Zaki, Amr; Loutfi, Mohamed; Sadaka, Mohamed; Ayad, Sherif; Kamal, Amr; Mokhtar, Ahmed; Investigator Group, Zeos

Correction: Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease

更正:依泽替米贝10/瑞舒伐他汀40联合疗法在埃及高危动脉粥样硬化性心血管疾病患者中的疗效和安全性

Sobhy, Mohamed; Badran, Hala Mahfouz; Hassanein, Mahmoud; Rafla, Samir; Zawawy, Tarek; Zaki, Amr; Loutfi, Mohamed; Sadaka, Mohamed; Ayad, Sherif; Kamal, Amr; Mokhtar, Ahmed; Investigator Group, Zeos